297 results
Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial
14 Feb 2022
The purpose of the prespecified subanalysis of the EXCEL (Evaluation of XIENCE versus Coronary artery bypass surgery for Effectiveness of Left main revascularization) trial was to determine whether the outcomes remained consistent regardless of geography.

Reviewer

Reviewer
One-year outcomes of blinded physiological assessment of residual ischemia after successful PCI - DEFINE PCI trial
10 Feb 2022
The objective of this analysis was to evaluate the impact of residual ischemia detected by post-PCI iFR on clinical outcomes and on residual-angina at the 12-month follow-up of the DEFINE PCI study.

Reviewer

Reviewer
Right ventricular-pulmonary arterial coupling and afterload reserve in patients undergoing transcatheter tricuspid valve repair
10 Feb 2022
The authors hypothesized that disordered right ventricular to pulmonary artery (RV-PA) coupling may denote RV decompensation in patients undergoing transcatheter tricuspid valve repair (TTVR) that may correlate with poor clinical outcomes.

Reviewer

Reviewer
Frequency and outcomes of periprocedural MI in patients with chronic coronary syndromes undergoing PCI
09 Feb 2022
This study evaluated the frequency and impact of periprocedural MI by using various MI definitions among patients with chronic coronary syndrome (CCS) undergoing percutaneous coronary intervention (PCI).

Reviewer
Improved 3-year cardiac survival after IVUS-guided long DES implantation: a patient-level analysis from 2 randomized trials
02 Feb 2022
This study aimed to increase the power to detect differences in patient survival (freedom from cardiac deaths) with IVUS versus angiography guidance by pooling the individual patient data from the IVUS-XPL and ULTIMATE trials.

Reviewer
Cardiohepatic syndrome is associated with poor prognosis in patients undergoing tricuspid transcatheter edge-to-edge valve repair
27 Jan 2022
As the prognostic role of cardiohepatic syndrome (CHS) has not yet been evaluated, Stolz et al. in the present study assessed its impact on T-TEER outcomes.

Reviewer

Reviewer
Ticagrelor monotherapy after PCI in high-risk patients with prior MI: a prespecified TWILIGHT substudy
31 Jan 2022
In this prespecified subgroup analysis of the TWILIGHT trial, the authors report the impact of prior MI on treatment effects of ticagrelor monotherapy compared to ticagrelor and aspirin in patients at least three months post PCI...

Reviewer
4-year outcomes after left atrial appendage closure versus Nonwarfarin oral anticoagulation for atrial fibrillation
24 Jan 2022
Left atrial appendage closure (LAAC) is a promising interventional treatment option for preventing cardioembolic events in non-valvular atrial fibrillation (AF) patients who can not tolerate long-term oral anticoagulation.

Reviewer
Cusp symmetry and coronary ostial eccentricity and its impact on coronary access following TAVR
26 Jan 2022
Recently, coronary access has been recognized as an important consideration in the lifetime management of patients with severe aortic stenosis...

Reviewer
30-day outcomes following transfemoral transseptal transcatheter mitral valve replacement: Intrepid TMVR early feasibility study results
21 Jan 2022
The study by Zahr et al. reports the results of an interim analysis assessing procedural and clinical outcomes at 30-day in 15 patients treated with the newly developed Medtronic Intrepid 35-F trans-femoral transcatheter mitral valve replacement (TMVR) system.

Reviewer